Drawing for INBRA

USPTO serial 79331434

INBRA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
OSGOOD, KRYSTINA E
Law office
TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INBRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical, surgical, dental and veterinary apparatus and instruments; artificial eyes and teeth; suture materials; tubing for medical use; medical suction and therapy apparatus; suction pumps for medical use; therapeutic and assistance devices designed for people with disabilities; apparatus, devices and articles for child care included in class 10; breast-milk storage bottles; massage apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 15, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 13, 2026CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jan 8, 2026CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 16, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 31, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 12, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 12, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 10, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 21, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 20, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 12, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 12, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 18, 2022RFNTREFUSAL PROCESSED BY IB—
Mar 31, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 31, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 2, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 1, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2022DOCKASSIGNED TO EXAMINER—
Jan 25, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 21, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 20, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance